title: Ammonia effect on calcium-activated chloride secretion in T84 intestinal epithelial monolayers.
abstract: We recently showed that ammonia profoundly inhibits cyclic nucleotide-regulated Cl- secretion in model human T84 intestinal epithelia but does not impair the secretory response to the Ca2+ agonist carbachol. Using transepithelial transport, fura 2 fluorescence, and radioisotopic efflux techniques, we further explored this dichotomy and arrived at a preliminary explanation for the inhibitory action of ammonia. The secretory response to the Ca(2+)-adenosinetriphosphatase inhibitor thapsigargin is unaffected by ammonia, which suggests that an increase in intracellular Ca2+ stimulates secretory pathways that are insensitive to ammonia. Surprisingly, Cl- secretion elicited by the Ca2+ ionophores ionomycin and A23187 is markedly blunted in monolayers pretreated with ammonia. However, ammonia posttreatment does not inhibit the secretory response to ionophore, which suggests that ammonia may interfere with the ability of these ionophores to increase intracellular [Ca2+]. This hypothesis is directly supported by fura 2 experiments. The inhibitory action of ammonia parallels the behavior of the K+ channel blocker Ba2+, and ammonia reduces the basolateral 86Rb+ efflux rate constant in forskolin- but not in carbachol-treated monolayers. Ammonia, which is present in high concentrations in the normal gastro-intestinal tract, may serve as a novel endogenous regulator of epithelial electrolyte transport by interfering with a Ba(2+)-sensitive basolateral K+ conductance distinct from the Ca(2+)-activated basolateral K+ conductance.
authors.affiliation: Department of Surgery, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Mayol
authors.forename: B J
authors.initials: BJ
authors.lastname: Hrnjez
authors.forename: H I
authors.initials: HI
authors.lastname: Akbarali
authors.forename: J C
authors.initials: JC
authors.lastname: Song
authors.forename: J A
authors.initials: JA
authors.lastname: Smith
authors.forename: J B
authors.initials: JB
authors.lastname: Matthews
mesh_terms: D000641:Ammonia / Q000494:pharmacology*; D001464:Barium / Q000494:pharmacology; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000819:agonists / Q000378:metabolism / Q000502:physiology*; D002217:Carbachol / Q000494:pharmacology; D002460:Cell Line; D002712:Chlorides / Q000037:antagonists & inhibitors / Q000378:metabolism*; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000819:agonists / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005456:Fluorescent Dyes; D016257:Fura-2; D006801:Humans; D007413:Intestinal Mucosa / Q000166:cytology / Q000378:metabolism*; D007425:Intracellular Membranes / Q000378:metabolism; D015759:Ionomycin / Q000494:pharmacology; D007476:Ionophores / Q000494:pharmacology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D019284:Thapsigargin / Q000494:pharmacology
chemical_list: D002712:Chlorides; D004791:Enzyme Inhibitors; D005456:Fluorescent Dyes; D007476:Ionophores; D005576:Colforsin; D001464:Barium; D000001:Calcimycin; D015759:Ionomycin; D019284:Thapsigargin; D000641:Ammonia; D002217:Carbachol; D000242:Cyclic AMP; D013755:Tetradecanoylphorbol Acetate; D002118:Calcium; D016257:Fura-2